Lower risk Medical device recall · FDA · Published November 4, 2021

Migo FLOWFLEX SARS-COV-2 Antigen Test: Not Authorized for Emergency Use

Migo Trading recalls FLOWFLEX SARS-COV-2 Antigen Rapid Tests due to lack of emergency use authorization. The product has not been validated for intended use and may not provide accurate results.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-0421-2022Medical device Migo Trading ›

Lower-risk recall

Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the stated intended use.

Take action

Contact the company

Recalling firmMigo Trading LLC831 Laca St · Dayton, NV 89403-6394

✎ GovInfoNow plain-language explainer

Migo Trading is recalling FLOWFLEX SARS-COV-2 Antigen Rapid Tests because they were not authorized for emergency use and have not been validated for the intended purpose. This means the tests might not work correctly for detecting the virus. Read more at govinfonow.com/recall/61588-migo-flowflex-sars-cov-2-antigen-test-not-authorized-for.

Source Summary by GovInfoNow · govinfonow.com/recall/61588-migo-flowflex-sars-cov-2-antigen-test-not-authorized-for · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0421-2022

Cite this page

“Migo FLOWFLEX SARS-COV-2 Antigen Test: Not Authorized for Emergency Use.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61588-migo-flowflex-sars-cov-2-antigen-test-not-authorized-for. Based on FDA recall #Z-0421-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0421-2022%22&limit=1).

Migo Trading LLC voluntarily recalled the FLOWFLEX SARS-COV-2 Antigen Rapid Test because it is inconsistent with its Emergency Use Authorization, according to the FDA. The agency announced the recall on November 4, 2021.

How to tell if you have it

Brand: Migo Trading
Product: FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test
UDI #: 6921756492427
Lot codes: COV1080232 (Expiration date: 05/13/2023); COV1095004 (Expiration date: 09/03/2023)
Distribution: NY
Units affected: 200,100

The hazard

The devices are inconsistent with the firm's Emergency Use Authorization. The product has not been authorized for emergency use and cannot be determined to be adequately validated for its intended use.

Context

GovInfoNow's records show other recent recalls of similar products include Wondfo Streptococcal A Test (2025-12-19), GET TESTED HPV Antigen Test (2025-11-03), and Covidien Mon-a-Therm Temperature Probe Recall (2026-04-23).

How to tell if you have this one

Check the product label for lot codes COV1080232 (expires 05/13/2023) or COV1095004 (expires 09/03/2023). The product is a single-test rapid antigen test for SARS-COV-2.

Brand
Migo Trading
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for lot codes COV1080232 or COV1095004 on the product label.

Where it went and when

Where it was distributed

Distributed in New York.

FDA distribution: “NY” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New York.

Recall timeline

FDA published this recall 2 months after the firm started it.

Nov 4, 2021Firm started the recall
Dec 27, 2021FDA classified it Class II
Jan 5, 2022Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

More Migo Trading recalls

Link to this recall

<a href="https://govinfonow.com/recall/61588-migo-flowflex-sars-cov-2-antigen-test-not-authorized-for">Migo FLOWFLEX SARS-COV-2 Antigen Test: Not Authorized for Emergency Use (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-0421-2022 (November 4, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0421-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.